13F filer · CIK 2012383 ↗
BlackRock
You are looking at Q1 2019. See the latest, Q2 2026 →
Reported value
$2.24T
+13% on the quarter before
Positions
4,966
233 new · 285 sold out
Top 10
14.4%
of the value
Est. gain
+$258.46B
on stocks held all quarter
Est. return
+13.4%
on those stocks since Q4 2018
Positions as of Mar 31, 2019, from BlackRock's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 25% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2018. Striped tiles are options.
Largest buys
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrCALL~$3.44BNew · 0.0% → 0.2%+12,181,100 underlying
- Walt Disney Company (The)~$1.80BAdded · 0.5% → 0.5%+16,253,685 shares
- Steris Plc~$1.09BNew · 0.0% → 0.0%+8,530,455 shares
- Barrick Gold Corporation~$867.5MAdded · 0.0% → 0.0%+63,276,124 shares
- Johnson & Johnson~$837.4MAdded · 1.2% → 1.2%+5,990,349 shares
- Alibaba~$724.3MAdded · 0.5% → 0.6%+3,969,960 shares
- Fox Corp~$724.3MNew · 0.0% → 0.0%+19,729,242 shares
- Verizon Communications Inc~$718.0MAdded · 0.9% → 0.8%+12,142,766 shares
- Medtronic Plc~$715.6MAdded · 0.5% → 0.4%+7,856,946 shares
- Jpmorgan Chase & Co~$694.9MAdded · 1.1% → 1.0%+6,864,576 shares
Largest sells
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Twenty First Centy Fox Inc~$3.00BSold out · 0.2% → 0.0%−62,250,574 shares
- SPDR S&P 500 ETF TrCALL~$1.52BSold out · 0.1% → 0.0%−6,062,800 underlying
- Apple~$1.49BCut · 2.4% → 2.4%−7,835,112 shares
- Twenty First Centy Fox Inc~$1.44BSold out · 0.1% → 0.0%−30,151,923 shares
- Eli Lilly~$1.02BCut · 0.4% → 0.4%−7,876,219 shares
- Microsoft~$955.8MCut · 2.6% → 2.6%−8,103,743 shares
- Steris Plc~$913.5MSold out · 0.0% → 0.0%−8,549,361 shares
- Bank Amer Corp~$892.8MCut · 0.7% → 0.7%−32,358,872 shares
- Cisco~$749.1MCut · 0.7% → 0.7%−13,874,440 shares
- Randgold Res Ltd~$743.9MSold out · 0.0% → 0.0%−9,094,109 shares
Holdings
As of Mar 31, 2019. Changes are in shares against Dec 31, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −1.6% · price +16.1% | 2.6% | $58.84B | +$8.17B | ||||||||
| AppleCOM · shares −2.6% · price +20.4% | 2.4% | $54.85B | +$9.30B | ||||||||
| AmazonCOM · shares −0.5% · price +18.6% | 2.0% | $45.71B | +$7.16B | ||||||||
| Johnson & JohnsonCOM · shares +3.3% · price +8.3% | 1.2% | $26.41B | +$1.96B | ||||||||
| MetaCL A · shares −1.4% · price +27.2% | 1.1% | $24.59B | +$5.25B | ||||||||
| AlphabetCAP STK CL C · shares −0.1% · price +13.3% | 1.0% | $22.99B | +$2.70B | ||||||||
| Exxon Mobil CorpCOM · shares −1.5% · price +18.5% | 1.0% | $22.61B | +$3.53B | ||||||||
| Jpmorgan Chase & CoCOM · shares +3.2% · price +3.7% | 1.0% | $22.47B | +$776.5M | ||||||||
| AlphabetCAP STK CL A · shares +0.04% · price +12.6% | 0.99% | $22.10B | +$2.48B | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares −0.4% · price −1.6% | 0.96% | $21.42B | −$350.9M | ||||||||
| Pfizer IncCOM · shares −3.7% · price −2.7% | 0.85% | $18.94B | −$526.2M | ||||||||
| Visa Inc.COM CL A · shares −0.7% · price +18.4% | 0.84% | $18.90B | +$2.93B | ||||||||
| Verizon Communications IncCOM · shares +4.1% · price +5.2% | 0.82% | $18.43B | +$871.8M | ||||||||
| Unitedhealth Group IncCOM · shares +0.2% · price −0.7% | 0.77% | $17.31B | −$129.9M | ||||||||
| Procter And Gamble CoCOM · shares −1.8% · price +13.2% | 0.77% | $17.22B | +$2.01B | ||||||||
| CiscoCOM · shares −4.3% · price +24.6% | 0.75% | $16.70B | +$3.30B | ||||||||
| IntelCOM · shares −3.1% · price +14.4% | 0.70% | $15.69B | +$1.98B | ||||||||
| Chevron Corp NewCOM · shares −0.6% · price +13.2% | 0.70% | $15.66B | +$1.83B | ||||||||
| Merck & Co IncCOM · shares −3.7% · price +8.8% | 0.70% | $15.59B | +$1.27B | ||||||||
| Bank Amer CorpCOM · shares −5.4% · price +12.0% | 0.70% | $15.58B | +$1.67B | ||||||||
| MastercardCL A · shares −1.1% · price +24.8% | 0.67% | $14.95B | +$2.97B | ||||||||
| AT&TCOM · shares −0.4% · price +9.9% | 0.63% | $14.21B | +$1.28B | ||||||||
| Wells Fargo Co NewCOM · shares −2.6% · price +4.9% | 0.62% | $13.92B | +$645.1M | ||||||||
| Ishares TrCORE S&P500 ETF · shares +2.7% · price +13.1% | 0.62% | $13.79B | +$1.55B | ||||||||
| Home Depot IncCOM · shares −0.4% · price +11.7% | 0.59% | $13.27B | +$1.39B | ||||||||
| Total · 4,966 positions | 100% | $2.24T | +$258.46B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2018 to Q1 2019: 4,547 stocks held throughout, up $258.46B (+13.4%).
- Apple+$9.30B+20%
- Microsoft+$8.17B+16%
- Amazon+$7.16B+19%
- Meta+$5.25B+27%
- Exxon Mobil Corp+$3.53B+18%
- Cme Group Inc−$565.5M−13%
- Cigna Corp New−$754.4M−15%
- Biogen Inc−$1.05B−21%
- Cvs Health Corp−$1.07B−18%
- Abbvie Inc−$1.10B−13%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 4 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 7, 2026 | $6.73T+18% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $5.72T−3% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $5.92T+4% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $5.71T+9% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $5.25T+10% | SEC ↗ |
| Q1 2025 | May 2, 2025 | $4.76T−4% | SEC ↗ |
| Q4 2024 | Feb 7, 2025 | $4.94T+4% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $4.76T+8% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $4.42T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 | $4.30T+10% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $3.92T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $3.48T−4% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $3.63T+7% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $3.39T+6% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $3.19T+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $2.94T−6% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $3.12T−16% | SEC ↗ |
| Q1 2022 | May 12, 2022 | $3.71T−6% | SEC ↗ |
| Q4 2021 | Feb 10, 2022 (amended) | $3.93T+10% | SEC ↗ |
| Q3 2021 | Nov 9, 2021 | $3.57T−1% | SEC ↗ |
| Q2 2021 | Aug 11, 2021 | $3.59T+6% | SEC ↗ |
| Q1 2021 | May 7, 2021 | $3.40T+9% | SEC ↗ |
| Q4 2020 | Feb 5, 2021 | $3.13T+16% | SEC ↗ |
| Q3 2020 | Nov 6, 2020 | $2.71T+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.51T+23% | SEC ↗ |
| Q1 2020 | May 1, 2020 | $2.04T−22% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $2.61T+10% | SEC ↗ |
| Q3 2019 | Nov 8, 2019 | $2.38T+2% | SEC ↗ |
| Q2 2019 | Aug 22, 2019 (amended) | $2.34T+4% | SEC ↗ |
| Q1 2019 | May 9, 2019 | $2.24T+13% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $1.98T−14% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $2.31T+6% | SEC ↗ |
| Q2 2018 | Aug 9, 2018 | $2.17T+4% | SEC ↗ |
| Q1 2018 | May 9, 2018 | $2.09T−0% | SEC ↗ |
| Q4 2017 | Feb 9, 2018 | $2.10T+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $1.98T+5% | SEC ↗ |
| Q2 2017 | Aug 10, 2017 | $1.89T+4% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $1.82T+2,478% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $70.66B+1% | SEC ↗ |
| Q3 2016 | Nov 8, 2016 | $69.66B+5% | SEC ↗ |
| Q2 2016 | Aug 10, 2016 | $66.46B+7% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $62.17B | SEC ↗ |